Psychosocial consequences of allocation to lung cancer screening: A randomised controlled trial

BMJ Open

Volumn 2, Issue 2, 2012, Pages

  Aggestrup, Louise Mosborg ^a   Hestbech, Mie Sara ^a   Siersma, Volkert ^a   Pedersen, Jesper Holst ^a   Brodersen, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BEHAVIOR; CANCER SCREENING; CONSEQUENCE OF SCREENING IN LUNG CANCER QUESTIONNAIRE; CONSEQUENCE OF SCREENING QUESTIONNAIRE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GUILT; HUMAN; INTROVERSION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SELF BLAME; SOCIAL PSYCHOLOGY;

EID: 84860900375     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000663     Document Type: Article

References (41)

1. Brodersen J, Jorgensen KJ, Gotzsche PC. The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn 2010;120:89-94.
2. Newman DH. Screening for breast and prostate cancers: moving toward transparency. J Natl Cancer Inst 2010;102:1008-11.
3. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13.
4. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med 2001;23:292-300. (Pubitemid 34087292)
5. Brodersen J, McKenna SP, Doward LC, et al. Measuring the psychosocial consequences of screening. Health Qual Life Outcomes 2007;5:3.
6. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008;28:917-25.
7. Domenighetti G, D'Avanzo B, Egger M, et al. Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32:816-21. (Pubitemid 37304647)
8. Scaf-Klomp W, Sanderman R, van de Wiel HB, et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997;51:705-10. (Pubitemid 28014250)
9. Brodersen J, Siersma V, Ryle M. Breast cancer screening: 'reassuring' the worried well? Scand J Public Health 2011;39:326-32.
10. Webster P, Austoker J. Women's knowledge about breast cancer risk and their views of the purpose and implications of breast screening-a questionnaire survey. J Public Health (Oxf) 2006;28:197-202. (Pubitemid 44418596)
11. Fallowfield LJ, Rodway A, Baum M. What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre? J R Soc Med 1990;83:547-51. (Pubitemid 20309006)
12. Jorgensen KJ, Klahn A, Gotzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med 2007;5:12.
13. The Danish National Board of Health. Death Cause Registry (In Danish). Dødsårsagsregisteret. 2009. http://www.sst.dk/publ/ Publ2010/DOKU/Registre/Doedsaarsagsregisteret2009.pdf
14. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105. (Pubitemid 29313143)
15. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. (Pubitemid 44631359)
16. McMahon PM, Christiani DC. Computed tomography screening for lung cancer. BMJ 2007;334:271. (Pubitemid 46293950)
17. Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-61. (Pubitemid 46376749)
18. Welch HG, Woloshin S, Schwartz LM, et al. Overstating the evidence for lung cancer screening: the International early lung cancer action program (I-ELCAP) study. Arch Intern Med 2007;167:2289-95. (Pubitemid 350179522)
19. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
20. Infante M, Cavuto S, Lutman FR, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-53.
21. Lopes PA, Picozzi G, Mascalchi M, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
22. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-14.
23. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74. (Pubitemid 46175408)
24. Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 2010;13:601-12.
25. Edelman S, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 1999;8:295-305. (Pubitemid 29417485)
26. Berglund G, Bolund C, Gustafsson UL, et al. Is the wish to participate in a cancer rehabilitation program an indicator of the need? Comparisons of participants and non-participants in a randomized study. Psychooncology 1997;6:35-46. (Pubitemid 27195761)
27. Saghir Z, Ashraf H, Dirksen A, et al. Contamination during 4 years of annual CT screening in the Danish lung cancer screening trial (DLCST). Lung Cancer 2010;71:323-7.
28. Lindstrom D, Sundberg-Petersson I, Adami J, et al. Disappointment and drop-out rate after being allocated to control group in a smoking cessation trial. Contemp Clin Trials 2010;31:22-6.
29. Brodersen J, Thorsen H. Consequences of screening in breast cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care 2008;26:251-6.
30. Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health 2007;10:294-304. (Pubitemid 47077254)
31. Moyer A, Knapp-Oliver SK, Sohl SJ, et al. Lessons to be learned from 25 years of research investigating psychosocial interventions for cancer patients. Cancer J 2009;15:345-51.
32. Ross L, Thomsen BL, Boesen EH, et al. In a randomized controlled trial, missing data led to biased results regarding anxiety. J Clin Epidemiol 2004;57:1131-7. (Pubitemid 39573019)
33. Lieberman MA, Golant M, Giese-Davis J, et al. Electronic support groups for breast carcinoma: a clinical trial of effectiveness. Cancer 2003;97:920-5. (Pubitemid 36173143)
34. Gades NM, Jacobson DJ, McGree ME, et al. Dropout in a longitudinal, cohort study of urologic disease in community men. BMC Med Res Methodol 2006;6:58.
35. Hestbech MS, Siersma V, Dirksen A, et al. Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 2011;73:325-31.
36. Idestrom M, Milsom I, Andersson-Ellstrom A. Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years. Acta Obstet Gynecol Scand 2002;81:962-7. (Pubitemid 35176989)
37. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003;56:52-60. (Pubitemid 36183315)
38. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long term consequences of false-positive screening mammography. J Med Screen 2004;11:39-44. (Pubitemid 38365694)
39. Hobart JC, Williams LS, Moran K, et al. Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke 2002;33:1348-56. (Pubitemid 34517059)
40. van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102:27-34.
41. van den Bergh KA, Essink-Bot ML, Bunge EM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008;113:396-404.